Your browser doesn't support javascript.
loading
Encapsulation of proteins from Leishmania panamensis into PLGA particles by a single emulsion-solvent evaporation method.
Ospina-Villa, Juan David; Gómez-Hoyos, Catalina; Zuluaga-Gallego, Robin; Triana-Chávez, Omar.
Afiliação
  • Ospina-Villa JD; Grupo Biología y Control de Enfermedades Infecciosas (BCEI), Sede de Investigación Universitaria, Universidad de Antioquia, Medellín, Colombia.
  • Gómez-Hoyos C; Programa de Ingeniería en Nanotecnología, Universidad Pontificia Bolivariana, Circular 1° N° 70-01, Medellín 050031, Colombia.
  • Zuluaga-Gallego R; Facultad de Ingeniería Agroindustrial, Universidad Pontificia Bolivariana, Circular 1° N° 70-01, Medellín 050031, Colombia.
  • Triana-Chávez O; Grupo Biología y Control de Enfermedades Infecciosas (BCEI), Sede de Investigación Universitaria, Universidad de Antioquia, Medellín, Colombia. Electronic address: omar.triana@udea.edu.co.
J Microbiol Methods ; 162: 1-7, 2019 07.
Article em En | MEDLINE | ID: mdl-31078626
The current therapy for the treatment of leishmaniasis is unsatisfactory because it has multiple side effects, and resistance has been reported among the parasites that cause these diseases. Numerous efforts have been made to develop new candidates for vaccines. In recent years, particles of biodegradable polymers have been proposed as vehicles to transport and protect antigens, proteins, drugs and vaccines. In this work, the oil/water (o/w) single emulsion-solvent evaporation technique was used to prepare PLGA biodegradable particles. The encapsulation of two hypothetical proteins from Leishmania panamensis was performed to validate the proposed method. For this validation, different concentrations (50, 100, 150, 200, 250, 500, and 750 µg/ml) of both proteins were encapsulated into PLGA particles, and the particle sizes and shapes were evaluated by optical microscopy and scanning electron microscopy (SEM), respectively. The release of proteins was confirmed by SDS-PAGE and Western blot analyses. The integrity of both proteins was conserved, and they were released from day one until day 15, with a maximum amount of 46 ±â€¯4.25% for the LpanUA.27.1260 protein and 26.19 ±â€¯3.41% for LpanUA.22.1860. Additionally, the protective efficacy of one of these encapsulated proteins was evaluated in vivo using BALB/c mice infected with L. panamensis. Therefore, the encapsulation of proteins is presented here as an excellent alternative to evaluate the antigenicity of proteins from parasites of medical importance such as L. panamensis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leishmaniose / Proteínas de Protozoários / Vacinas contra Leishmaniose / Copolímero de Ácido Poliláctico e Ácido Poliglicólico / Leishmania Limite: Animals País/Região como assunto: America central / Panama Idioma: En Revista: J Microbiol Methods Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leishmaniose / Proteínas de Protozoários / Vacinas contra Leishmaniose / Copolímero de Ácido Poliláctico e Ácido Poliglicólico / Leishmania Limite: Animals País/Região como assunto: America central / Panama Idioma: En Revista: J Microbiol Methods Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Holanda